Structure of full antagonist and efficient degrader of ERα, GNE-149

monovalent degrader + full antagonist of ER_

orally efficacious in xenograft model

from ligand-based design of full antag.

ACS Med. Chem. Lett., May 29, 2020

Genentech, South San Francisco, CA

GNE-149 is an efficient monovalent degrader and full antagonist of estrogen receptor alpha with significant oral bioavailability in higher species. The standard-of-care selective ER degrader (SERD) fulvestrant is not orally…

 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.